All our production efforts are now addressing the COVID-19 crisis. To keep up with the extremely high demand, we developed a special formulation optimized for SARS-CoV-2 detection, which enables us to use the maximum capacity of our production facility.
The new SOLIScript® 1-step CoV Kit is validated by a national laboratory on real positive COVID-19 samples using WHO listed US-CDC and Berlin-Charité protocols. Several diagnostic kit manufacturers already use our SOLIScript® 1-step CoV Kit as a universal component with their SARS-CoV-2 RT-qPCR diagnostic panels.
Download the fact sheet and let us know if You are interested in testing this kit. We are happy to send You additional information and a free sample for testing.
Our kit is stable at room temperature in liquid form for 30 days, which makes it easy to use and allows ice-free shipping. Routine storage upon arrival at -20 °C. The product is available in two kit sizes – in 250 and 5000 reaction kits. Bulk formats are available upon request.
This summer we got to collaborate with a fun project organized by the MINT Campus in Germany. Not only does MINT campus inspire children and young people about these topics but it also introduces young people to sustainable, innovative developments in current research and technology.
Whether you are studying the genetic material of plants, brains or viruses, the experiment usually starts with extracting RNA from the sample material. It would be incredibly useful to get all the RNA extracted instead of it getting destroyed by the RNases before even starting the cDNA synthesis step. But how can we protect the RNA when RNases are all around us? Let’s find out!
There aren’t many people who can lead teams as well as our Head of Quality and Product Management Eva-Maria does. She is like that red string on a mystery board connecting all the departments. If you would like to get a little closer to solving the great leadership puzzle that Eva-Maria has mastered, have a look at the following story.
On the 4th and 5th of June representatives from South Korea visited Tartu. Their primary focus was on exploring opportunities in the fields of biotechnology and medicine, seeking potential collaborators in Estonia. We had the great pleasure of meeting the delegation and sharing our knowledge on both days of the visit.
